Sale disclosed
Fred Aslan
Chief Executive Officer
Common Stock
- Reported value
- $168.88K
- Reported price
- $7.1977 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
Artiva Biotherapeutics, Inc.
Last 30 daysNo qualifying insider buying. Sales: $981.89K by 4 insiders.
Showing the first 6 of 72 trades on this page.
Chief Executive Officer
Common Stock
Chief Tech Operations Officer
Common Stock
COO, CLO, Compliance Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & Head of R&D
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & Head of R&D
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Tech Operations Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Tech Operations Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
COO, CLO, Compliance Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
COO, CLO, Compliance Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Medical Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Executive Officer
Common Stock
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Director Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Chief Tech Operations Officer
Common Stock
COO, CLO, Compliance Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Executive Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Chief Medical Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Related filings are retained as evidence. This economic transaction is counted once.
This amendment supersedes the related original transaction.
Original SEC filing ↗Amended SEC filing ↗Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Related filings are retained as evidence. This economic transaction is counted once.
This original record remains available as evidence. The later filing replaces it in totals and buying signals.
Superseding SEC filing ↗Original transaction filing ↗Common Stock
Excluded from the common-share buying signal. See trade details.
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
Director
Common Stock
10% owner
Common Stock
10% owner
Common Stock
SVP, Research and Development
Common Stock
Chief Tech Operations Officer
Common Stock
COO, CLO, Compliance Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Executive Officer
Common Stock
President & Head of R&D
Common Stock
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
President & Head of R&D
Employee Stock Option (Right to Buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
Director
Pre-Funded Warrant (Right to Buy)
Derivative security · not the ordinary share price.
Excluded from the common-share buying signal. See trade details.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Chief Executive Officer | Common StockSale10b5-1 | 23,463$7.20 / share | $168.88K | Oct 6Filed Oct 7 · 1d later | SEC filing |
| Chief Tech Operations Officer | Common StockSale | 10,340$6.84 / share | $70.7K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| COO, CLO, Compliance Officer | Common StockSale | 8,370$6.84 / share | $57.23K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chief Medical Officer | Common StockSale | 1,099$6.84 / share | $7.51K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chief Executive Officer | Common StockSale | 61,696$6.84 / share | $421.83K | Oct 5Filed Oct 6 · 1d later | SEC filing |
| Chief Executive Officer | Common StockGrant or award | 110,000Award · no purchase price | Non-cash award | Sep 15Filed Sep 15 · 0d later | SEC filing |
| Chief Executive Officer | Employee Stock Option (Right to Buy)Grant or award | Derivative units315,000Award · no purchase price | Non-cash award | Sep 15Filed Sep 15 · 0d later | SEC filing |
| Chief Executive Officer | Common StockGrant or award | 45,000Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Chief Executive Officer | Employee Stock Option (Right to Buy)Grant or award | Derivative units155,000Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| +5Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units16,250Award · no purchase price | Non-cash award | Sep 10Filed Sep 14 · 4d later | SEC filing |
| President & Head of R&D | Common StockGrant or award | 45,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| President & Head of R&D | Employee Stock Option (Right to Buy)Grant or award | Derivative units135,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| Chief Tech Operations Officer | Common StockGrant or award | 40,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| Chief Tech Operations Officer | Employee Stock Option (Right to Buy)Grant or award | Derivative units120,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| COO, CLO, Compliance Officer | Common StockGrant or award | 45,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| COO, CLO, Compliance Officer | Employee Stock Option (Right to Buy)Grant or award | Derivative units135,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| Chief Medical Officer | Common StockGrant or award | 30,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| Chief Medical Officer | Employee Stock Option (Right to Buy)Grant or award | Derivative units85,000Award · no purchase price | Non-cash award | Sep 9Filed Sep 11 · 2d later | SEC filing |
| Chief Executive Officer | Common StockSale10b5-1 | 23,429$10.92 / share | $255.75K | Sep 8Filed Sep 9 · 1d later | SEC filing |
| +5Director | Director Stock Option (Right to Buy)Grant or award | Derivative units13,750Award · no purchase price | Non-cash award | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units13,750Award · no purchase price | Non-cash award | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units13,750Award · no purchase price | Non-cash award | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units13,750Award · no purchase price | Non-cash award | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units13,750Award · no purchase price | Non-cash award | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units13,750Award · no purchase price | Non-cash award | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Director | Director Stock Option (Right to Buy)Grant or award | Derivative units13,750Award · no purchase price | Non-cash award | Sep 8Filed Sep 8 · 0d later | SEC filing |
| Chief Tech Operations Officer | Common StockSale | 10,366$11.16 / share | $115.64K | Sep 3Filed Sep 4 · 1d later | SEC filing |
| COO, CLO, Compliance Officer | Common StockSale | 8,391$11.16 / share | $93.61K | Sep 3Filed Sep 4 · 1d later | SEC filing |
| Chief Medical Officer | Common StockSale | 1,100$11.16 / share | $12.27K | Sep 3Filed Sep 4 · 1d later | SEC filing |
| Chief Executive Officer | Common StockSale | 61,888$11.16 / share | $690.39K | Sep 3Filed Sep 4 · 1d later | SEC filing |
| Chief Medical Officer | Common StockOption exercise or conversion10b5-1 | 5,306$1.92 / share | $10.19K | Aug 27Filed Aug 31 · 4d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-1 | 8,222$12.01 / share | $98.74K | Aug 27Filed Aug 31 · 4d later | SEC filing |
| Chief Medical Officer | Employee Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units5,306$1.92 exercise / conversion price | Not a separate purchase | Aug 27Filed Aug 31 · 4d later | SEC filing |
| Chief Medical Officer | Common StockOption exercise or conversion10b5-1 | 429$1.92 / share | $823.68 | Aug 18Filed Aug 19 · 1d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-1 | 429$12.00 / share | $5.15K | Aug 18Filed Aug 19 · 1d later | SEC filing |
| Chief Medical Officer | Employee Stock Option (Right to Buy)Option exercise or conversion10b5-1 | Derivative units429$1.92 exercise / conversion price | Not a separate purchase | Aug 18Filed Aug 19 · 1d later | SEC filing |
| +5Director | Common StockPurchase | 20,824$9.99 / share | $208.03K | Jul 29Filed Jul 31 · 2d later | SEC filing |
| +5Director | Common StockPurchase | 24,944$9.93 / share | $247.69K | Jul 31Filed Jul 31 · 0d later | SEC filing |
| +5Director | Common StockPurchase | 41,319$9.99 / share | $412.78K | Jul 24Filed Jul 28 · 4d later | SEC filing |
| +5Director | Common StockPurchase | 120,582$9.55 / share | $1.15M | Jul 21Filed Jul 23 · 2d later | SEC filing |
| +5Director | Common StockPurchase | 84,124$9.93 / share | $835.35K | Jul 22Filed Jul 23 · 1d later | SEC filing |
| +5Director | Common StockPurchase | 59,880$9.96 / share | $596.4K | Jul 23Filed Jul 23 · 0d later | SEC filing |
+5DirectorAmendedRelated filings are retained as evidence. This economic transaction is counted once. This amendment supersedes the related original transaction. Original SEC filing ↗Amended SEC filing ↗ | Common StockPurchase | 6,522$8.94 / share | $58.31K | Jul 13Filed Jul 23 · 10d later | SEC filing |
| +5Director | Common StockPurchase | 152,472$8.93 / share | $1.36M | Jul 16Filed Jul 20 · 4d later | SEC filing |
| +5Director | Common StockPurchase | 7,882$8.95 / share | $70.54K | Jul 17Filed Jul 20 · 3d later | SEC filing |
| +5Director | Common StockPurchase | 15,102$8.97 / share | $135.46K | Jul 10Filed Jul 14 · 4d later | SEC filing |
+5DirectorSuperseded by later filingRelated filings are retained as evidence. This economic transaction is counted once. This original record remains available as evidence. The later filing replaces it in totals and buying signals. Superseding SEC filing ↗Original transaction filing ↗ | Common StockPurchaseExcluded from purchase score | 6,552$8.94 / share | Unavailable | Jul 13Filed Jul 14 · 1d later | SEC filing |
| +5Director | Common StockPurchase | 31,000$8.88 / share | $275.28K | Jun 25Filed Jun 29 · 4d later | SEC filing |
| +5Director | Common StockPurchase | 1,876$8.98 / share | $16.85K | Jun 26Filed Jun 29 · 3d later | SEC filing |
| +5Director | Common StockPurchase | 391,019$8.57 / share | $3.35M | Jun 12Filed Jun 16 · 4d later | SEC filing |
| +5Director | Common StockPurchase | 15,414$8.99 / share | $138.57K | Jun 15Filed Jun 16 · 1d later | SEC filing |
| +5Director | Common StockPurchase | 124,893$8.89 / share | $1.11M | Jun 16Filed Jun 16 · 0d later | SEC filing |
| +5Director | Common StockPurchase | 479,039$6.91 / share | $3.31M | Jun 9Filed Jun 11 · 2d later | SEC filing |
| +5Director | Common StockPurchase | 103$7.00 / share | $721 | Jun 10Filed Jun 11 · 1d later | SEC filing |
| +5Director | Common StockPurchase | 548,580$7.91 / share | $4.34M | Jun 11Filed Jun 11 · 0d later | SEC filing |
| +110% owner | Common StockPurchase2 trades | 1,432,291avg $11.52 / share | $16.5M | May 11Filed May 28 · 17d later | 2 filings
|
| SVP, Research and Development | Common StockSale | 3,095$9.01 / share | $27.88K | May 19Filed May 19 · 0d later | SEC filing |
| Chief Tech Operations Officer | Common StockSale | 7,002$9.01 / share | $63.07K | May 19Filed May 19 · 0d later | SEC filing |
| COO, CLO, Compliance Officer | Common StockSale | 8,790$9.01 / share | $79.18K | May 19Filed May 19 · 0d later | SEC filing |
| Chief Medical Officer | Common StockSale | 7,037$9.01 / share | $63.39K | May 19Filed May 19 · 0d later | SEC filing |
| Chief Executive Officer | Common StockSale | 27,116$9.01 / share | $244.25K | May 19Filed May 19 · 0d later | SEC filing |
| President & Head of R&D | Common StockGrant or award | 77,500Award · no purchase price | Non-cash award | May 18Filed May 19 · 1d later | SEC filing |
| President & Head of R&D | Employee Stock Option (Right to Buy)Grant or award | Derivative units232,500Award · no purchase price | Non-cash award | May 18Filed May 19 · 1d later | SEC filing |
| +5Director | Common StockPurchase | 6,510,416$11.52 / share | $75M | May 11Filed May 13 · 2d later | SEC filing |
| +5Director | Pre-Funded Warrant (Right to Buy)PurchaseExcluded from purchase score | Derivative units2,170,138$11.52 / derivative unit | $25M | May 11Filed May 13 · 2d later | SEC filing |
$28,803,280 of common-equity purchase value after transaction-age decay across 180 days.
2 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
This reflects the filings imported so far, not a complete trading history.